Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1745 of 6351
-
New hope for celiac sufferers: drug targets stubborn symptoms despite Gluten-Free diet
Disease control Recruiting nowA study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet
Phase 2 • Sponsor: Dr. Falk Pharma GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Sound waves aim to stop hand cramps in musicians and writers
Disease control Recruiting nowThe purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating task specific focal hand dystonias (TSFD). TSFD is a type of dystonia that affects hand movements during specific tasks such as writing, playing instruments …
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Predicting vision recovery after eye surgery for high myopia
Knowledge-focused Recruiting nowThis prospective pilot study evaluates factors that predict outcomes after vitrectomy for myopic foveoschisis (MFS), a sight-threatening complication of high myopia that can lead to progressive visual loss, foveal detachment, macular holes, and retinal detachment. Although vitrec…
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New heart implant aims to prevent strokes without blood thinners
Disease control Recruiting nowAtrial fibrillation (AF) is responsible for 15-20% of ischaemic strokes. These events are often caused by thrombus formation in the left atrium. Thromboembolic risk in AF is primarily prevented by oral anticoagulation. However, this drug-based approach has a number of limitations…
Sponsor: French Cardiology Society • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can brain training apps help veterans with TBI think clearer?
Symptom relief Recruiting nowFor many Veterans, success in achieving goals at work, school and in other aspects of life are top priorities. The abilities to regulate attention, remember key information, and stay calm and on track are fundamental to this success. Unfortunately, Veterans who have experienced a…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Are Europe's heart patients getting the right prevention care? a massive survey aims to find out
Knowledge-focused OngoingThe goal of this observational study is to provide a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary heart disease (CHD), individuals at high cardiovascular disease risk and all thos…
Sponsor: European Society of Cardiology • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Diabetes drug may also protect bones, early trial hints
Disease control OngoingThe hypothesis for this study is that oral Semaglutide, a GLP-1Ra, has a positive effect on the balance between build-up and degradation as well as the strength of the bones in men and women aged 50-85 years with type 2 diabetes and an increased risk of bone fractures. Treatment …
Phase 2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Virtual reality could make hand hygiene stick
Knowledge-focused CompletedHealthcare-associated infections (HAIs) are an important patient safety concern, and hand hygiene is one of the most effective measures for preventing their transmission. However, hand hygiene compliance among healthcare professionals, including nurses, remains suboptimal. Innova…
Sponsor: Askin Selvi • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Blood test may predict breast cancer return after chemo
Knowledge-focused Recruiting nowThe EXActDNA-003 study will prospectively enroll participants who are planning to undergo chemotherapy for high-risk, early breast cancer, who are willing to provide tissue and blood specimens for circulating tumor DNA (ctDNA) analysis. Participants will be followed for up to 5.…
Sponsor: Exact Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Gut health boost could slow kidney disease, new trial hopes
Disease control Recruiting nowChronic kidney disease (CKD) has become a major public health problem worldwide. Patients with CKD are often accompanied by azotemia due to impaired renal function and excretion of nitrogen metabolic waste, which leads to multiple organ dysfunction, cardiac dysfunction and other …
Phase 4 • Sponsor: Chujin Cao • Aim: Disease control
Last updated Jun 26, 2026 19:19 UTC
-
New study tests belimumab to tame early lupus
Disease control OngoingThis is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody positive early SLE with ongoing disease activity despite stable first-line SLE therapy.
Phase 4 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can texting and online support help latino men with HIV stay on track?
Disease control Recruiting nowThe goal of this study is to evaluate the efficacy of stepped care strategies to improve ART adherence among adult Latino men with HIV using a sequential, multiple assignment, randomized trial (SMART). The trial will compare a stepped care strategy of delivering TXTXT ("Treatment…
Sponsor: Florida International University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Radiation beads plus immunotherapy: a new hope for inoperable bile duct cancer?
Disease control Recruiting nowThis phase I trial tests the safety and side effects of yttrium-90 (Y90) radioembolization combined with immunotherapy drugs tremelimumab and durvalumab in treating patients with intrahepatic cholangiocarcinoma (cancer of the bile ducts in the liver) that has spread to nearby tis…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug aimed at regrowing hair in severe alopecia
Disease control Stopped earlyThis is a parallel, Phase 2 multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study to investigate the efficacy and safety of subcutaneous (SC) injections of amlitelimab treatment as monotherapy in participants aged 18 years and older with severe alo…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
One inhaler to rule them all? new asthma study for kids
Disease control Recruiting nowThis is a Phase 3 single-centre open label randomised controlled trial with two equal sized groups to assess the efficacy of budesonide/formoterol 80/4.5 (6-11 years) and 160/4.5 (12-18 years) compared to the standard of care in reducing asthma exacerbations over 52 weeks. Child…
Phase 3 • Sponsor: University of KwaZulu • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for Hard-to-Treat cancers: experimental drug targets KRAS mutation
Disease control Recruiting nowThis study is a multicentre, open phase I clinical study of dose escalation, dose extension and efficacy extension of HRS-7058 in subjects with advanced malignant tumour. To evaluate the safety, tolerability, pharmacokinetics and efficacy of HRS-7058.
Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Nose cells could fix your knee: new implant trial launches
Disease control Recruiting nowThe purpose of this investigator-initiated study is to assess the efficacy of treating patellofemoral osteoarthritis with an Advanced Therapy Medicinal Product (ATMP), autologous nasal chondrocyte tissue engineered cartilage (N-TEC), in comparison with a standard therapy using pl…
Phase 2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New gel could help heal diabetic foot wounds
Disease control OngoingThe goal of this multi-center, randomized, controlled, evaluator-blinded study is to assess and measure the safety and efficacy of NOX1416 as an adjunct to standard of care (SOC) in the treatment of chronic, non-healing, diabetic foot ulcers (DFUs). Subjects will be randomized to…
Phase 1 • Sponsor: NOxy Health Products, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Gene therapy trial aims to fix enzyme defect in fabry disease
Disease control Recruiting nowThe main goals of this clinical study are to characterize safety and PK/PD of AMT-191 i.e. if drug doses used in the study are safe and tolerable and to understand how it acts in the body of people with Fabry disease.
Phase 1/2 • Sponsor: UniQure Biopharma B.V. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Brain imaging may expose a shared marker in PTSD and alcohol addiction
Knowledge-focused Recruiting nowThe overall objective of this study it to use Positron Emission Tomography (PET) brain imaging and a radiotracer that measures the epigenetic marker Histone Deacetylase 6 (HDAC6) to examine HDAC6 expression in people with Post-Traumatic Stress Disorder (PTSD), Alcohol Use Disorde…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC